Axogen, Inc.
AXGN· Nasdaq
AXGNAxogen, Inc.
Filed Mar 1, 2017 · 10-K · 60 days after period end · 0001558370-17-001241
| Metric | Q4 2016 | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures |
|---|---|---|---|---|
| Revenue | $11.41M | $7.81M | $4.79M | $2.98M |
| Net Income | -$5.63M | -$3.61M | -$6.49M | -$4.11M |
| EPS Diluted | -$0.17 | — |
Axogen, Inc. · CIK 805928 · Engraved from SEC EDGAR
| — |
| — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2016 · filed Mar 1, 2017 · 60 d after period end
